Navigation Links
Miramar Labs Names Zoromski As CEO
Date:10/13/2008

MENLO PARK, Calif., Oct. 13 /PRNewswire/ -- Miramar Labs (http://www.miramarlabs.com/), a startup dermatologic medical device company based in Menlo Park, CA, has named Darrell Zoromski as President and CEO. Zoromski joins Miramar from Align Technology, where he was Chief Marketing Officer and Global Vice President. Align is a global manufacturer and distributor of Invisalign-branded aligner trays that straighten teeth.

"Darrell brings an impressive record of entrepreneurial marketing leadership to Miramar," says Mark Deem, Interim President & CEO of Miramar and Chief Technology Officer of The Foundry, where Miramar Labs was incubated. Prior to his position at Align, Zoromski held marketing management positions of increasing responsibilities at Sola/Zeiss Vision Company, Pillsbury, S.C. Johnson, and Proctor & Gamble. Notes Deem: "At each stop in his career, Darrell has led the establishment of innovative new technologies while growing market share and profitability." Zoromski is a graduate of the Kellogg Graduate School of Management at Northwestern University, where he earned is MBA in marketing, and of the University of Wisconsin, where he earned his BA in finance, international business and marketing.

Miramar was launched in 2006 with a Series "A" round financing of $5 million from The Foundry's two venture capital backers, Morgenthaler Ventures and Split Rock Partners. In February 2008, Domain Associates led a "B" round financing of $22-million, in which Morgenthaler, and Split Rock also invested.

Miramar represents the 11th company incubated at The Foundry (http://www.the-foundry.com), widely recognized as the world's premier medical device incubator. Founded in 1998, The Foundry has created such companies as Concentric Medical, Emphasys, Evalve, Satiety, Xtent, which have combined valuations of over $1-billion and employ more than 600 people.


'/>"/>
SOURCE Miramar Labs
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Weight Watchers Names Steven C. McCormick as President, North America
2. TransEnterix Inc. Names Experienced Medical Device Executive Todd M. Pope as President, CEO
3. Adaptis Names Bruce Pym to the Board Of Directors
4. ASTRO Names New Research Director, Health Policy Analyst
5. Hooper Holmes Names Richard Whitbeck President of Portamedic Division
6. ArunA Biomedical Names Harold Ingalls to its Board of Directors
7. Older Vietnamese report more mental health problems
8. USP announces new tool to help prevent medication mix-ups due to look alike/sound alike drug names
9. Malaria No More Names Scott Case Chief Executive Officer
10. Prematics Names Dean M. Panovich Vice President, Deployment
11. Fidelity Southern Corporation Names Brolly Interim CFO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... ... enough sleep affects much more than energy – it also has mental and physical benefits. ... motor reaction time, which can increase the risk of having a car accident. , ... the NSF to help you sleep better and feel better:, , ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... http://www.wiredlifesolutions.com , “Computers are everywhere and they’re here to stay,” said ... Global Climate Change and Your Health on Voice America sponsored by Nature’s Tears® ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... The ... board members and officers for 2017-2018. The annual board election process has been in ... a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Children and adolescents who ... experiences than children in the general population. That’s because foster care is designed ... family challenges. While no fault of their own, youth who have experienced trauma ...
(Date:4/28/2017)... Harbor, Md. (PRWEB) , ... April 28, 2017 ... ... Care Association of America (UCAOA) and College of Urgent Care Medicine will host ... 2017 workshops, sessions and speakers will help those in the industry adapt to ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment ... projected period The Cardiology Devices segment is likely ... US$ 15 Mn in 2018 over 2017. By the end ... market valuation close to US$ 700 Mn, expanding at a ... segment dominated the Asia Pacific reprocessed ...
Breaking Medicine Technology: